Rx-101005

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameRx-101005
Drug Alias Namedihydrofolate reductase inhibitor (Trius)DHFR inhibitors (Trius)antibacterials (Trius Therapeutic)Rx-101079
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionDihydrofolate reductase inhibitors
TargetsDihydrofolate reductase
Therapy Area/IndicationsMycosesBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTrius Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTrius Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsMycosesBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A